Skip to content
Palanor is in early release, with our founding customers.Become a founding customer →
PalanorPalanor

Stacked bars

FDA AI-Enabled Medical Devices by Specialty

AI-enabled devices authorized per year by the FDA review panel that led the review

Total 335 in 2025the highest in data back to 1995+333 since 1995
Current·Data to 2025
RadiologyCardiovascularNeurologyAll other specialties

Plays the chart through its history. Pauses are where the data set a record or moved most.

FDA list of AI-enabled medical devices, by date of final decision and lead review panel. Other: anesthesiology, gastroenterology-urology, hematology, pathology, ophthalmic, surgery and the rest.

Which medical specialties the FDA’s AI-enabled devices serve. Radiology accounts for most of them in every year; cardiology and neurology follow far behind.

What this chart reads

Sources

FDA AI-Enabled Device Authorizations: Radiology (Annual). Source: U.S. Food and Drug Administration, "Artificial Intelligence-Enabled Medical Devices" list (fda.gov/medical-devices/artificial-intelligence-enabled-medical-devices), read from the CSV the list page links. Palanor counts devices by Date of Final Decision. FDA website policies: "Unless otherwise noted, the contents of the FDA website (www.fda.gov) — both text and graphics — are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA." Read weekly.

FDA AI-Enabled Device Authorizations: Cardiovascular (Annual). Source: U.S. Food and Drug Administration, "Artificial Intelligence-Enabled Medical Devices" list (fda.gov/medical-devices/artificial-intelligence-enabled-medical-devices), read from the CSV the list page links. Palanor counts devices by Date of Final Decision. FDA website policies: "Unless otherwise noted, the contents of the FDA website (www.fda.gov) — both text and graphics — are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA." Read weekly.

FDA AI-Enabled Device Authorizations: Neurology (Annual). Source: U.S. Food and Drug Administration, "Artificial Intelligence-Enabled Medical Devices" list (fda.gov/medical-devices/artificial-intelligence-enabled-medical-devices), read from the CSV the list page links. Palanor counts devices by Date of Final Decision. FDA website policies: "Unless otherwise noted, the contents of the FDA website (www.fda.gov) — both text and graphics — are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA." Read weekly.

FDA AI-Enabled Device Authorizations: Other Specialties (Annual). Source: U.S. Food and Drug Administration, "Artificial Intelligence-Enabled Medical Devices" list (fda.gov/medical-devices/artificial-intelligence-enabled-medical-devices), read from the CSV the list page links. Palanor counts devices by Date of Final Decision. FDA website policies: "Unless otherwise noted, the contents of the FDA website (www.fda.gov) — both text and graphics — are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA." Read weekly.

Charts are drawn from Palanor's signal library and recomputed from source data on every view. Transformations (changes, indexing, year-on-year rates) are Palanor's.

Related charts

HealthForecast

Drug Stocks Against the Market

Twenty large U.S.-listed drugmakers (by market value) and the S&P 500, price indexed to the start of the window

197.2Data yesterday
HealthForecast

U.S. Uninsured Rate

Share of people in the United States with no health insurance, annual, %

8.2%Data to Dec 2024
HealthForecast

U.S. Drug Overdose Deaths

Drug overdose deaths in the U.S., 12 months ending each month

66,478Data to May 2026
HealthForecast

FDA Novel Drug Approvals

New drugs approved by the FDA’s drug center, trailing 12 months

59Data 51 days ago
Health· StudioForecast

FDA Novel Drug Approvals, Trailing 12 Months

New molecular entities and new therapeutic biologics approved by FDA's Center for Drug Evaluation and Research.

59.0Data 51 days ago
HealthForecast

Donor Aid for Health

Bilateral aid disbursements from DAC member countries by sector, US$ billions, current prices, yearly

$7.3B1 viewsData to Dec 2024

Cookies

We only use essential cookies to keep you signed in and remember your theme. No analytics, no tracking, no ads. See the Privacy Policy for the full read.